Additionally, gastric cancer progression is associated with the lncRNA LINC00673 through the interaction with LSD1 and EZH2, leading to inhibition of KLF2 and LATS2 expression to exert oncogenic functions in vitro and in vivo [58]. Here, EZH2 is linked to gastric cancer.